Ipamorelin — The Cleanest Growth Hormone Secretagogue Available

Ipamorelin

In the development of growth hormone releasing peptides, each successive compound has been an attempt to solve the problems of the one before it. GHRP-6 was potent but produced significant appetite stimulation, cortisol elevation and prolactin rise alongside its GH release. GHRP-2 was more potent still but carried an even broader hormonal footprint. Hexarelin produced the strongest GH pulse of all but with the most pronounced desensitisation and secondary hormonal effects of the entire family.

Then Novo Nordisk developed Ipamorelin in the 1990s with a different priority entirely. Rather than maximum potency, the goal was maximum selectivity — a compound that would stimulate robust GH release through the ghrelin receptor while producing as little off-target hormonal activity as possible. Ipamorelin is called the first truly selective growth hormone secretagogue because it stimulates GH release without measurably raising cortisol, prolactin or ACTH at therapeutic doses. Fortune

That selectivity is the defining characteristic of Ipamorelin and the reason it has become the most widely used standalone GHRP in the research community. Understanding what that selectivity means in practice, where it matters most and why it makes Ipamorelin the preferred choice for ongoing daily use, is what this page is here to provide.

For those interested in the combination of Ipamorelin with CJC-1295 — the most widely used GH peptide stack — the full combined protocol is covered in detail on the [CJC-1295 with Ipamorelin] page. This page focuses specifically on Ipamorelin as a standalone compound.

What Is Ipamorelin?

Ipamorelin is a synthetic pentapeptide growth hormone secretagogue that stimulates the pituitary gland to release growth hormone. It belongs to the growth hormone releasing peptide family and acts on the ghrelin receptor GHS-R1a, but unlike other GHRPs such as GHRP-6 and GHRP-2, Ipamorelin is highly selective. It triggers a robust GH pulse without significantly raising cortisol, prolactin or appetite. This selectivity is what makes Ipamorelin the most popular standalone GHRP and the preferred choice for users who want the benefits of increased growth hormone without the side effects associated with less selective peptides. ScienceDirect

Its amino acid sequence — Aib-His-D-2Nal-D-Phe-Lys-NH2 — incorporates non-proteinogenic residues that support the receptor selectivity and metabolic stability that distinguish it from its predecessors. These structural features were the result of deliberate rational drug design aimed at creating a compound that preferentially engaged GHS-R1a with minimal interaction at non-target pituitary receptors.

How Does Ipamorelin Work?

Ipamorelin works by binding to and activating GHS-R1a, the ghrelin receptor on pituitary somatotroph cells, triggering a pulsatile release of growth hormone. This is the same fundamental mechanism as GHRP-6 and Hexarelin — the difference lies entirely in what else it does and, crucially, what it does not do.

Ipamorelin’s selectivity is its defining characteristic. Unlike GHRP-6 which stimulates intense hunger and raises cortisol, or GHRP-2 which also increases prolactin, Ipamorelin produces a clean GH pulse with minimal off-target hormonal effects. This selectivity comes from its specific receptor binding profile — it activates GHSR-1a efficiently without strong activation of the pathways responsible for cortisol release and appetite stimulation. Wellbeing Nutrition

Ipamorelin preserves the natural pulsatile rhythm of growth hormone release rather than forcing a continuous elevation, maintaining normal feedback regulation. This is a practically important characteristic for anyone using GH peptides on an ongoing daily basis. The preservation of pulsatile GH release means the body’s own regulatory systems remain intact and responsive throughout the protocol, reducing the risk of the downregulation and desensitisation that continuous or unphysiological GH elevation can produce. Fortune

The practical implications of this selectivity profile are significant. Someone using Ipamorelin does not need to manage appetite stimulation around their injection windows. They do not need to be concerned about chronic cortisol or prolactin elevation across an extended protocol. They can use it daily for longer periods than Hexarelin or GHRP-6 allow before desensitisation becomes a meaningful concern. And they can combine it with a wide range of other compounds without worrying about cumulative hormonal load.

Ipamorelin vs GHRP-6 and Hexarelin

The comparison between Ipamorelin and the other GHRPs in the library is one of the most practically useful things this page can offer, because choosing between them shapes the entire experience and duration of a GH peptide protocol.

Ipamorelin produces a strong and clean GH pulse with no meaningful cortisol, prolactin or appetite effects. It is suitable for ongoing daily use over extended periods. It desensitises more slowly than GHRP-6 or Hexarelin. Its GH pulse amplitude is lower than Hexarelin and broadly comparable to GHRP-6, though the absence of the secondary hormonal footprint means the net hormonal environment it creates is considerably cleaner.

GHRP-6 produces a stronger appetite stimulation that is valuable in bulking contexts but challenging in fat loss or body composition protocols. Its cortisol and prolactin effects are more pronounced and require more active management. It is better suited to shorter intensive cycles than ongoing daily protocols.

Hexarelin produces the most potent GH pulse of any injectable GHRP but with the most significant secondary hormonal effects and the most pronounced desensitisation, requiring strict 4-week-on-4-week-off cycling. It is best suited to advanced researchers running short intensive cycles rather than ongoing daily GH optimisation.

The conclusion for most people entering the GH peptide research space is straightforward. Ipamorelin is the right starting point and the right ongoing choice for daily use. GHRP-6 or Hexarelin are considerations for more advanced protocols with specific goals that justify their broader hormonal profiles.

What Does the Research Show?

The mechanism is real, the selectivity has been demonstrated in human pharmacokinetic studies and the theoretical benefit profile is plausible. What is missing is large-scale outcome data — no large randomised controlled trial has yet shown that Ipamorelin improves body composition, sleep quality or recovery in a controlled human population. Fortune

The human pharmacokinetic data from the original Novo Nordisk development programme, published in the late 1990s, established Ipamorelin’s GH releasing profile and selectivity in healthy human subjects. This remains the most directly relevant controlled human data for the compound’s core mechanism.

The broader evidence base relies on extrapolation from the well-established relationship between GH and IGF-1 levels and the outcomes that GH peptide research is targeting, including body composition improvement, recovery enhancement, sleep quality and the broad spectrum of regenerative effects associated with optimised GH levels across the lifespan.

The regulatory situation in 2026 reflects the evidence position accurately. In October 2023 the FDA designated Ipamorelin as a Category 2 bulk drug substance, prohibiting compounding by licensed pharmacies. As of April 2026, regulatory reclassification efforts have been underway with some movement toward restoring certain peptides including Ipamorelin to Category 1 status which would permit evaluated compounding under regulatory oversight. This regulatory situation remains fluid and subject to change. nih

Where Ipamorelin Standalone Makes Most Sense

The CJC-1295 with Ipamorelin combination is covered in full on its own dedicated page and is the most widely used and best supported approach for most GH peptide research goals. Ipamorelin standalone makes most sense in specific circumstances.

For someone who wants to start with a single compound before adding CJC-1295, beginning with Ipamorelin alone for 4 to 8 weeks establishes a clear baseline for how the compound affects sleep quality, recovery and wellbeing before the GHRH component is added.

For bridging the off-weeks of a Hexarelin cycle, Ipamorelin provides lower-level GH stimulus during the rest period without adding to the receptor desensitisation that the Hexarelin cycle has created. The different receptor pharmacology means Ipamorelin use during a Hexarelin break does not meaningfully impair receptor recovery.

For anyone whose primary concern is the secondary hormonal effects of the other GHRPs and who prioritises the cleanest possible GH profile above maximum pulse amplitude, Ipamorelin standalone represents the most selective and manageable ongoing GH peptide option available.

Dosage and Protocol

Standard Ipamorelin Standalone Protocol:

Dose: 100 to 300mcg per injection
Frequency: Once to three times daily depending on goal. Once daily pre-sleep is the most commonly used approach. Twice daily, morning fasted and pre-sleep, is used by those seeking more sustained GH elevation throughout the day
Timing: Fasted state for maximum GH pulse amplitude. A minimum of two hours without food before injection and at least 30 minutes after before eating. The pre-sleep window is the most productive single daily administration point, aligning the Ipamorelin-driven GH pulse with the body’s natural overnight GH release
Cycle length: 12 to 16 weeks, significantly longer than Hexarelin or GHRP-6 given the lower desensitisation rate, followed by a break of 4 to 8 weeks
Combination: When combined with CJC-1295 without DAC, both compounds are drawn into the same syringe and administered as a single injection. Full combination protocol details are on the [CJC-1295 with Ipamorelin] page

Reconstitution and Mixing Guide

Ipamorelin typically comes as lyophilised powder in vials of 2mg or 5mg.

Using a 5mg (5,000mcg) vial as the reference:

Add 1ml of bacteriostatic water:

Concentration = 5,000mcg per ml
Each unit on a 100-unit insulin syringe = 50mcg
A 100mcg dose = 2 units
A 200mcg dose = 4 units
A 300mcg dose = 6 units

Add 2ml of bacteriostatic water (most commonly used ratio):

Concentration = 2,500mcg per ml
Each unit on a 100-unit insulin syringe = 25mcg
A 100mcg dose = 4 units
A 200mcg dose = 8 units
A 300mcg dose = 12 units

Add 5ml of bacteriostatic water:

Concentration = 1,000mcg per ml
Each unit on a 100-unit insulin syringe = 10mcg
A 100mcg dose = 10 units
A 200mcg dose = 20 units
A 300mcg dose = 30 units

For most people adding 2ml to a 5mg vial creates the most practical working concentration with straightforward unit calculations across all standard dose levels.

Reconstitution Method

Inject bacteriostatic water slowly down the inside wall of the vial rather than directly onto the powder. Gently swirl rather than shake until fully dissolved. The solution should be clear and colourless.

Storage

Reconstituted Ipamorelin should be refrigerated at 2 to 8 degrees Celsius and used within 28 to 30 days. Do not freeze a reconstituted vial. Lyophilised powder should be refrigerated away from light and moisture until reconstituted.

Supporting Supplements

The supplements that most coherently support Ipamorelin’s clean GH releasing mechanism are those that complement the growth hormone axis it activates and the recovery and body composition goals it is most commonly used to support.

Zinc and Magnesium are the most directly relevant. Zinc supports GH synthesis and IGF-1 signalling. Magnesium supports the deep sleep quality in which the overnight GH pulse Ipamorelin amplifies is most significant. Taking both before the pre-sleep injection is a well-reasoned and commonly used approach.

Vitamin D maintains the hormonal and metabolic environment in which GH activity produces the most meaningful body composition and recovery results. Its widespread deficiency in the UK population makes supplementation particularly relevant.

Protein at adequate daily intake provides the amino acids that elevated IGF-1 activity will use for tissue repair and lean tissue development. Without sufficient protein the anabolic signal has insufficient raw material.

Vitamin C supports immune function and the anti-inflammatory environment relevant to anyone using GH peptides for recovery and performance goals.

Collagen peptides taken with Vitamin C before sleep complement Ipamorelin’s pre-sleep protocol by providing the structural building blocks for the connective tissue repair that elevated GH activity supports during the overnight window.

Foods That Complement Ipamorelin

The most important nutritional consideration for Ipamorelin is the fasted window around each injection. Food intake close to injection time elevates insulin which directly blunts GH release, making the timing of meals relative to injections the most important nutritional variable in any Ipamorelin protocol.

The pre-sleep injection window requires a clean fast of at least two hours after the last meal. Avoiding carbohydrates and dietary fats in the two hours before the pre-sleep injection preserves the GH pulse most effectively. A small protein-only snack earlier in the evening is acceptable but heavier meals should be completed well before the injection window.

Through the rest of the day the nutritional approach that best supports Ipamorelin’s effects centres on lean protein at every meal, healthy fats, adequate fibre and reduced refined carbohydrates. Stable blood sugar and an anti-inflammatory food base create the metabolic environment in which GH activity translates most effectively into body composition and recovery improvements.

Oily fish two to three times per week delivers omega-3 fatty acids that support cardiovascular health and the anti-inflammatory environment in which tissue repair and recovery occur most effectively. Alcohol directly impairs GH release, disrupts sleep architecture and elevates cortisol, working against everything Ipamorelin is trying to achieve.

Lifestyle Considerations

Sleep quality is the lifestyle factor of greatest importance for anyone using Ipamorelin in a pre-sleep protocol. The overnight GH pulse that Ipamorelin amplifies is the body’s largest natural daily GH release, and the quality of slow-wave sleep during which that pulse occurs determines how effectively the compound’s effects are expressed. Protecting sleep duration and architecture throughout the protocol is one of the highest leverage actions available.

Resistance training interacts with Ipamorelin’s GH releasing mechanism synergistically. Exercise-induced GH stimulation and the Ipamorelin-driven GH pulse both work through the pituitary, and the combination of physical training demand and ghrelin receptor activation produces a more substantial combined response than either generates alone.

Consistency is particularly important with Ipamorelin given that its benefits are gradual and cumulative rather than immediate and dramatic. The improvements in sleep quality, recovery and body composition that a well-structured Ipamorelin protocol produces develop progressively over weeks rather than days. Consistent daily administration at consistent timing is what allows those cumulative benefits to develop fully.

Stress management remains relevant even with Ipamorelin’s clean cortisol profile. Chronic stress creates elevated baseline cortisol that antagonises the GH signalling Ipamorelin is working to optimise, regardless of the compound’s own cortisol-neutral profile.

Peptide Pairing

CJC-1295 without DAC is the most natural, most widely used and most evidence-supported pairing with Ipamorelin. The GHRH receptor activation of CJC-1295 and the ghrelin receptor activation of Ipamorelin produce a synergistic GH pulse significantly greater than either generates independently. The full combined protocol is covered on the [CJC-1295 with Ipamorelin] page.

BPC-157 pairs coherently with Ipamorelin for the active person who wants both GH axis optimisation and tissue repair support running simultaneously. The two compounds address completely different biological systems with no meaningful interaction concerns.

TB-500 similarly complements Ipamorelin by addressing systemic tissue repair during the day while Ipamorelin drives GH release across its active windows.

IGF-1 LR3 is sometimes used alongside Ipamorelin in advanced protocols, with Ipamorelin driving the upstream GH stimulus and IGF-1 LR3 providing direct downstream IGF-1 receptor activation on training days. This combination addresses the GH axis from both the hypothalamic-pituitary level and the peripheral tissue level simultaneously.

Realistic Expectations

Ipamorelin is the most appropriate starting point for anyone new to GH peptides and the most sustainable ongoing choice for daily GH optimisation across extended periods. Its clean selectivity profile, the absence of appetite stimulation, cortisol or prolactin effects and its lower desensitisation rate relative to GHRP-6 and Hexarelin make it the compound that is easiest to use, easiest to manage and most compatible with a wide range of other protocols.

The improvements most consistently reported across the research community include meaningfully improved sleep quality, typically noticeable within the first two to four weeks, followed by enhanced recovery from training, progressive improvements in body composition over a 12 to 16 week cycle, and the broader spectrum of effects associated with optimised GH levels including improved skin quality, joint health and sustained energy.

The mechanism is real and the selectivity has been demonstrated in human studies. What the evidence base currently lacks is large-scale controlled outcome data in healthy populations. For those engaging with Ipamorelin as a research compound with an understanding of that evidence position, consistent daily use within a well-structured protocol that includes appropriate nutrition, sleep and resistance training delivers results that the research community consistently reports as meaningful and well-tolerated across extended periods. Fortune

Used consistently, at appropriate doses, with fasted injection timing and the lifestyle and nutritional foundations this site covers in depth, Ipamorelin earns its position as the most widely used and most trusted standalone growth hormone secretagogue available.